Milestone Scientific, Inc. (MLSS) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
220 SOUTH ORANGE AVENUE LIVINGSTON, NJ 07039 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 8,715 | 14,764 | 14,224 | 1,516 | 743 | 2,637 | |||
| Cash and cash equivalents | 8,715 | 14,764 | 14,224 | 1,516 | 743 | 2,637 | |||
| Short-term investments | |||||||||
| Receivables | 694 | 943 | 1,081 | 1,711 | 2,078 | 3,761 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,792 | 1,542 | 2,420 | 1,621 | 1,921 | 3,379 | |||
| Inventory | 1,792 | 1,542 | 2,420 | 1,621 | 1,921 | 3,379 | |||
| Deferred costs | 50 | 1,110 | |||||||
| Advances on inventory purchases | 1,325 | 1,309 | 414 | 711 | 649 | 697 | |||
| Other undisclosed current assets | 444 | 375 | 416 | 535 | 415 | 436 | |||
| Total current assets: | 12,971 | 18,934 | 18,555 | 6,093 | 5,856 | 12,020 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 18 | ✕ | ✕ | ||||||
| Operating lease, right-of-use asset | 444 | 551 | 632 | ✕ | ✕ | ||||
| Property, plant and equipment | 18 | 24 | 31 | 45 | 83 | 142 | |||
| Long-term investments and receivables | 650 | ||||||||
| Accounts and financing receivable, after allowance for credit loss | 650 | ||||||||
| Intangible assets, net (including goodwill) | 228 | 278 | 329 | 382 | 435 | 2,790 | |||
| Intangible assets, net (excluding goodwill) | 228 | 278 | 329 | 382 | 435 | 2,790 | |||
| Other noncurrent assets | 24 | 24 | 24 | 36 | 27 | 27 | |||
| Total noncurrent assets: | 732 | 876 | 1,017 | 463 | 545 | 3,608 | |||
| TOTAL ASSETS: | 13,702 | 19,810 | 19,571 | 6,556 | 6,401 | 15,629 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,228 | 2,198 | 1,307 | 2,154 | 2,687 | 3,266 | |||
| Accounts payable | 1,103 | 780 | 483 | 1,379 | 1,205 | 978 | |||
| Accrued liabilities | 1,125 | 1,417 | 824 | 775 | 1,482 | 2,288 | |||
| Debt | 9 | 9 | 284 | 16 | |||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 1,725 | ||
| Due to related parties | 803 | 396 | 385 | 1,359 | 1,664 | 986 | |||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 100 | ✕ | ||
| Other undisclosed current liabilities | 259 | 495 | 901 | 1,398 | 422 | 752 | |||
| Total current liabilities: | 3,300 | 3,097 | 2,878 | 4,928 | 4,873 | 6,728 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 11 | 497 | 587 | ||||||
| Finance lease, liability | 11 | 20 | 29 | ✕ | ✕ | ||||
| Liabilities, other than long-term debt | 385 | ||||||||
| Operating lease, liability | 385 | 477 | 558 | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | (477) | (558) | 1,400 | ||||||
| Total noncurrent liabilities: | 396 | 497 | 587 | 1,400 | |||||
| Total liabilities: | 3,696 | 3,594 | 3,464 | 4,928 | 4,873 | 8,128 | |||
| Equity | |||||||||
| Equity, attributable to parent | 10,226 | 16,368 | 16,201 | 1,696 | 1,540 | 7,244 | |||
| Preferred stock | 0 | 0 | |||||||
| Common stock | 69 | 68 | 64 | 49 | 36 | 35 | |||
| Treasury stock, value | (912) | (912) | (912) | (912) | (912) | (912) | |||
| Additional paid in capital | 127,478 | 124,916 | 117,935 | 96,082 | 88,415 | 86,689 | |||
| Accumulated deficit | (116,410) | (107,704) | (100,886) | (93,524) | (86,000) | (78,568) | |||
| Equity, attributable to noncontrolling interest | (219) | (153) | (94) | (67) | (11) | 257 | |||
| Total equity: | 10,006 | 16,215 | 16,107 | 1,629 | 1,528 | 7,501 | |||
| TOTAL LIABILITIES AND EQUITY: | 13,702 | 19,810 | 19,571 | 6,556 | 6,401 | 15,629 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 8,806 | 10,305 | 5,437 | 8,375 | 9,622 | 11,282 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 11,282 | |
| Cost of revenue (Cost of Goods and Services Sold) | (3,905) | (3,993) | (1,816) | (2,656) | (5,191) | (4,313) | ||
| Gross profit: | 4,901 | 6,312 | 3,621 | 5,718 | 4,431 | 6,969 | ||
| Operating expenses | (13,728) | (13,690) | (11,074) | (9,717) | (12,431) | (12,204) | ||
| Operating loss: | (8,827) | (7,379) | (7,453) | (3,999) | (7,999) | (5,234) | ||
| Nonoperating income (expense) | (25) | (3,646) | 0 | 4 | ||||
| Investment income, nonoperating | (3,636) | 7 | 9 | |||||
| Other nonoperating expense | (25) | (10) | (7) | (5) | ||||
| Interest and debt expense | 276 | |||||||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 55 | (16) | 7 | 2 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (8,773) | (7,119) | (7,471) | (7,643) | (7,999) | (5,230) | ||
| Income (loss) from equity method investments | 243 | 98 | 81 | 330 | (121) | |||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Loss from continuing operations before income taxes: | (8,773) | (6,876) | (7,373) | (7,562) | (7,669) | (5,350) | ||
| Income tax expense | (0) | (16) | (18) | (24) | (19) | |||
| Loss from continuing operations: | (8,773) | (6,876) | (7,389) | (7,580) | (7,693) | (5,370) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (6,876) | (7,389) | (7,580) | (7,693) | (5,370) | ||
| Other undisclosed net income | 2 | |||||||
| Net loss: | (8,773) | (6,876) | (7,389) | (7,580) | (7,692) | (5,370) | ||
| Net income attributable to noncontrolling interest | 67 | 58 | 52 | 56 | 260 | 183 | ||
| Net loss available to common stockholders, diluted: | (8,706) | (6,818) | (7,337) | (7,524) | (7,432) | (5,187) | ||
Comprehensive Income ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (8,773) | (6,876) | (7,389) | (7,580) | (7,692) | (5,370) | ||
| Comprehensive loss: | (8,773) | (6,876) | (7,389) | (7,580) | (7,692) | (5,370) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 67 | 58 | 52 | 56 | 260 | 183 | ||
| Comprehensive loss, net of tax, attributable to parent: | (8,706) | (6,818) | (7,337) | (7,524) | (7,432) | (5,187) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.